We are live on ! Find out more
NITE

Nightstar Therapeutics plc American Depositary Shares
NITE

Delisted

NITE was delisted on the 6th of June, 2019.

16 hedge funds and large institutions have $108M invested in Nightstar Therapeutics plc American Depositary Shares in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

133% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 3

25% less capital invested

Capital invested by funds: $143M → $108M (-$35.2M)

45% less funds holding

Funds holding: 2916 (-13)

81% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 16

Holders
16
Holders Change
-13
Holders Change %
-44.83%
% of All Funds
0.36%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
7
Reduced
3
Closed
16
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VF
26
Virtu Financial
New York
-$427K -22,253 Closed
Citadel Advisors
27
Citadel Advisors
Florida
-$240K -12,500 Closed
HHC
28
Hutchin Hill Capital
New York
-$240K -12,500 Closed
Deutsche Bank
29
Deutsche Bank
Germany
-$92K -4,800 Closed
FMA
30
FNY Managed Accounts
New York
-$66K -3,440 Closed
Bank of Montreal
31
Bank of Montreal
Ontario, Canada
-$25K -1,300 Closed
CCA
32
Catalyst Capital Advisors
New York
-$6K -310 Closed

NITE Hedge Fund Activity: Q4 2017 in Review

16 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Nightstar Therapeutics plc American Depositary Shares (NITE) for Q4 2017, worth a combined $108M — down 25% from $143M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of NITE and 3 opened new positions — a net loss of 13 holders — while 3 trimmed existing stakes and 7 added.

The largest buyer was Wellington Management Group, adding an estimated $16M. The largest seller was BlackRock, exiting entirely with an estimated $6.24M sold.

  • 16 institutional investors held Nightstar Therapeutics plc American Depositary Shares (NITE) as of Q4 2017, down from 29 in Q3 2017.
  • Funds reported $108M of Nightstar Therapeutics plc American Depositary Shares stock for Q4 2017, down 25% quarter-over-quarter.
  • 3 funds opened new Nightstar Therapeutics plc American Depositary Shares positions in Q4 2017 and 16 closed out, a net change of -13 holders.
  • The largest Nightstar Therapeutics plc American Depositary Shares buyer in Q4 2017 was Wellington Management Group, an estimated $16M added.
  • The largest Nightstar Therapeutics plc American Depositary Shares seller in Q4 2017 was BlackRock, an estimated $6.24M sold.

Based on aggregated 13F filings for Q4 2017.